← Eichor
Study identifier: NCT07669987 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Impact of Preoperative Quantitative Flow Reserve (QFR) on Early Postoperative Radial Artery Graft Outcomes in Coronary Artery Bypass Grafting

Condition: Quantitative Flow Reserve · Minimally Invasive Coronary Surgery · Radial Artery  ·  Sponsor: Peking University Third Hospital

PhaseN/A
Planned participants110
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this observational study is to learn about the long-term effects of Quantitative Flow Reserve (QFR) assessment in patients undergoing Coronary Artery Bypass Grafting (CABG). The main question it aims to answer is: Does preoperative QFR measurement improve graft outcomes and reduce major adverse cardiac and cerebrovascular events (MACE) in patients undergoing CABG? Participants who are scheduled for CABG and have undergone preoperative QFR assessment will be followed for one year post-surgery. They will provide data on graft patency and report any occurrences of MACE through regular follow-up visits and questionnaires about their health status.

This description comes directly from the study's public registry record.

Talk to the study team

Tong Ding, MD  ·  +8613132150173  ·  dt1067723747@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking university third hospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07669987